• James Dargan
• May 9, 2026
• 7 min read

Swiss startup Moonlight AI has closed a $3.3 million seed round co-led by Lotus One Investment, VP Venture Partners, and MEDIN Fund, with participation from N&V Capital and QAI Ventures, to advance AI-powered image analysis for clinical oncology diagnostics.

Founded by CEO Christian Ruiz, CTO Nicole Romano, and CMO Stefan Habringer, the company uses computer vision to detect genomic biomarkers directly from routine blood and cytology slide imaging, bypassing the high cost and slow turnaround of conventional genomic sequencing. The technology targets hematologists and pathologists treating blood cancers including MDS, chronic lymphocytic leukemia, and non-small cell lung cancer.

Funding will support expansion of a proprietary dataset linking whole slide imaging with genomic data, built through an international clinical consortium, alongside team growth and regulatory approval processes.

Featured image: Credit: Moonlight AI